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Abstract
Introduction
The existence of partial volume effects in brain MR images makes it challenging to under-
stand physio-pathological alterations underlying signal changes due to pathology across
groups of healthy subjects and patients. In this study, we implement a new approach to dis-
entangle gray and white matter alterations in the thalamus and the basal ganglia. The pro-
posed method was applied to a cohort of early multiple sclerosis (MS) patients and healthy
subjects to evaluate tissue-specific alterations related to diffuse inflammatory or neurode-
generative processes.
Method
Forty-three relapsing-remitting MS patients and nineteen healthy controls underwent 3T MRI
including: (i) fluid-attenuated inversion recovery, double inversion recovery, magnetization-
prepared gradient echo for lesion count, and (ii) T1 relaxometry. We applied a partial volume
estimation algorithm to T1 relaxometry maps to gray and white matter local concentrations
as well as T1 values characteristic of gray and white matter in the thalamus and the basal
ganglia. Statistical tests were performed to compare groups in terms of both global T1 val-
ues, tissue characteristic T1 values, and tissue concentrations.
Results
Significant increases in global T1 values were observed in the thalamus (p = 0.038) and the
putamen (p = 0.026) in RRMS patients compared to HC. In the Thalamus, the T1 increase
was associated with a significant increase in gray matter characteristic T1 (p = 0.0016) with
no significant effect in white matter.
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Conclusion
The presented methodology provides additional information to standard MR signal averag-
ing approaches that holds promise to identify the presence and nature of diffuse pathology
in neuro-inflammatory and neurodegenerative diseases.
Introduction
Magnetic resonance (MR) imaging provides in vivo information about brain tissue integrity
[1]. The MR signal varies across tissue types because gray matter (GM) contains a prevalence
of cell bodies (neurons, glial cells, etc....) and iron, while white matter (WM) is for the majority
constituted by neuronal fibers (myelinated and unmyelinated axons) [2,3]. Nevertheless, as cell
bodies are common in WM, a certain amount of neuronal fibers is also present in cortical and
sub-cortical GM [4]. The variation of the MR signal due to the mixture of different tissues in
the same region is known as the “partial volume” (PV) effect. In deep gray matter nuclei
(DGMN), the PV effect modulates the MR signal across and throughout the anatomical struc-
tures due to presence of neuronal fibers in varying amount. The globus pallidus shows higher
intensity in T1-weighted images (close to WM T1) than other DGMN, due to its relatively
higher myelin content [5]. On the other hand, the putamen is characterized by higher T1 inten-
sity in its caudal part when compared to the rest of its structure, due to the presence of myelin-
ated axons [6].
Because of this, the analysis of the GM andWM alterations in the DGMN is challenging.
Standard approaches based on global signal averaging compare mean intensities over regions
of interest. While such methods may detect changes across different populations, they do not
provide enough information to attribute such changes to specific changes in the GM or WM
components of the MR signal.
In the recent past, a number of MRI approaches based on the combination of different con-
trasts, have been proposed to visualise cortical myelination and differentiate the cellular from
neuronal fibers component in the brain cortex. Glasser et al. computed the ratio between T1-
and T2-weighted MR images as a measure of cortical myelin content [7], while Grydeland com-
bined this ratio with diffusion MRI information to achieve more accurate results [8]. More
recently, Shafee et al. performed cortical myelin content estimation using a mixture model of
GM andWM in both T1- and T2-weighted images. As to deep GM structures (thalamus and
basal ganglia), there have been a few attempts to separate their tissue components based on
advanced MRI techniques like relaxometry and magnetization transfer imaging [6] or quanti-
tative susceptibility mapping [9]. These approaches provide measures directly linked with the
biological properties of the tissue. The longitudinal relaxation time T1 which is very sensitive
to the structural coherence of the tissue, provides a very good contrast between the GM and
WM. The magnetization transfer imaging is based on the signal of the macromolecules com-
posing the tissue, and is particularly sensitive to myelin [10]. These multi-contrast approaches
have the potential to provide evidence of demyelination processes, but may be insensitive to
changes in GM properties, which may occur in others pathologies.
In this work, we aim to characterize both the GM andWM components of the DGMN by
disentangling their respective contributions to the MR signal. We use a method of partial vol-
ume estimation previously described and validated in (Roche and Forbes, MICCAI 2014) [11]
by comparison with the MNI BrainWeb phantom (http://brainweb.bic.mni.mcgill.ca/
brainweb/).
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In the sequel, we describe our tissue separation method, and further present its application
to a group comparison study between early relapsing remitting multiple sclerosis (RRMS)
patients and healthy controls.
Method
Population
We studied nineteen healthy controls (HC, 33 ± 9.3 years mean ± standard deviation (SD), 11
women and 8 men, gender ratio: 1.7) and forty-three RRMS patients (35.2 ± 10 years
mean ± SD, 27 women and 16 men, gender ratio: 1.4).
Subjects gender ratio and age showed no significant differences between controls and RRMS
patients group.
All patients were scanned less than 6 years after the initial symptoms (33 ± 20 months,
range 2–70 months) and the disease diagnosis (27 ± 17 months, range 0–59 months). Patients
had a low lesion load considering the early stage of the disease (mean total lesion volume per
patient: 5 ± 2 mL).
Thirty patients were under immunomodulatory treatment (high dosage interferon beta or
fingolimod) for at least 3 months, the rest of the patients were not under treatement at the time
of the MRI. No patient had received corticosteroid therapy within the 3 months preceding the
enrollment.
The ethics committee of the University Hospital of Lausanne (CHUV) approved the study.
Written informed consent was obtained from each subject.
Multiple sclerosis data acquisition
All subjects underwent the following protocol: (i) 3D magnetization-prepared acquisition with
gradient echo (MPRAGE) (TR/TE = 2300/2.89 ms, voxel size = 1.0x1.0x1.2 mm3,
FoV = 256x256x256, acquisition time = 5:12 min), (ii) a prototype 3D magnetization-prepared
2 acquisitions with gradient echo (MP2RAGE) [12] (TR/TE = 5000/2.89 ms, voxel
size = 1x1x1.2 mm3, FoV = 256x256x256 acquisition time = 8:22 min), (iii) a high-resolution
3D fluid-attenuated inversion recovery (FLAIR) (TR/TE/TI = 5000/394/1800 ms, voxel
size = 1x1x1.2 mm3, FoV = 256x256x256, acquisition time = 6:27 min); and (iv) a 3D double
inversion recovery (DIR) (TR/TE/TI = 10000/218/3650 ms, voxel size = 1x1x1.2 mmm3,
FoV = 256x256×256, acquisition time = 12:52 min). All acquisitions were performed on a 3T
MAGNETOM Trio (Siemens, Erlangen, Germany) equipped with a 32-channel head coil. The
MPRAGE sequence was used for atlas-based segmentation of the DGMN. The MP2RAGE,
FLAIR and DIR sequences were used to detect and segment MS lesions in the brain. The
MP2RAGE sequence also provided a whole-brain T1 relaxometry map [12].
A group of 9 healthy subjects (30.2 ± 5 years mean ± SD, 6 women and 3 men) also elected
to participate in the 7T study, underwent a MP2RAGE sequence at 7T. A visual inspection of
image quality was performed for all subjects.
Image processing
Regions-of-interest extraction. We applied the MorphoBox software [13] to the
MPRAGE volumes to segment the following deep GM regions: thalamus, caudate, putamen
and pallidum. MorphoBox automatically delineates ROIs by performing a non-rigid registra-
tion to a template, previously manually defined by a neurologist and two neuroradiologists by
consent. In order to work only with normal-appearing tissue, we excluded MS lesions from
each DGMN. The lesions were manually identified and delineated by an experienced
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neurologist (CG) and a radiologist (DR) using FLAIR, DIR and MP2RAGE images. Then
lesions masks were created using the methodology previously reported in [14].
Concentration map and tissue intensities. The intensity of a voxel in an MR image
depends on the specific imaging technique used and the type of molecules present in the voxel
volume. In a T1 relaxometry map, the voxel intensity represents the longitudinal relaxation
time of the tissue and is driven by the density and type of molecules that compose the tissue.
The microstructure of the DGMN is mainly characterized by neurons and glial cells (GM com-
ponent) as well as neuronal fibers (WM component) [2], which have a different impact on the
MRI signal. To separate GM andWM components in a DGMN and estimate their respective
contributions to the T1 intensity, we applied a partial volume estimation algorithm developed
by Roche A. et al. [11], which operates from a model that describes each voxel intensity as the
sum of GM andWM characteristic intensities (which are global to DGMN) weighted by their
respective concentrations (which are local), with Gaussian noise:
yi ¼ mGMCGM þ mWMCWM þ εi
with
εi ¼ Nð0; sÞ
where yi is the intensity of a voxel i, CGM and CWM are the associated concentrations of GM
andWM, μGM and μWM the characteristic tissue intensities, i.e. the intensities corresponding to
100% of GM andWM, respectively; εi represents the noise and σ its standard deviation, which
is also estimated by the PV algorithm.
After we initialized both μGM and μWM to standard T1 values at 3T for GM (1350 ms) and
WM (850 ms) [12], the algorithm iteratively estimated GM andWM concentrations (CGM,
CWM) and their characteristic intensities μGM and μWM for each voxel: (Step 1) the algorithm
estimates tissue concentration maps assuming tissue characteristic values μGM and μWM; (Step
2) it re-computes the characteristic intensities μGM and μWM of GM andWM based on the con-
centration maps previously estimated. These two steps were iterated 10 times to provide stable
estimates of both GM andWM concentration maps and T1 characteristic intensities for each
DGMN. See an example of GM concentration map in the supplementary data (S1 Fig).
Qualitative assessment
In order to illustrate the extracted GM andWM components, we compared GM concentration
maps estimated for 3 healthy subjects at 3T and 7T with histological slices obtained from one
healthy subject at the level of the DGMN [15,16]. The 3 healthy subjects (32.2 ± 3 years
mean ± SD, 2 women and 1 man) were chosen randomly among the 9 HC who were scanned
at 3T and 7T.
The histological images were stained using Nissl to highlight the cell bodies, and Luxol blue
to show myelin of axons (Fig 1) [15].
Group comparison analysis
We subsequently performed a group analysis to compare RRMS patients and controls using:
(i) a multivariate analysis of the variances (MANOVA) of the estimated pooled T1 intensities
of GM andWM as well as the ratio between GM andWM concentrations (CGM / CWM), (ii) a
global averaging technique of the T1 intensity.
All statistical analysises were corrected for multiple comparison using Bonferroni correction
or the family-wise error rate [17], and age and sex were used as covariates.
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The MANOVA was performed using R software (http://www.R-project.org) and tested the
following H0 hypothesis: there are no differences between RRMS patients and controls in the
WM and GM pooled intensities (μGM and μWM) and in the concentration ratio (CGM / CWM) of
thalamus, caudate, putamen, and pallidum. In order to identify the contribution of GM and
WM characteristic intensities and concentration to the differences observed with the multivari-
ate analysis, we performed two-tailed permutation-based two-sample t-tests between RRMS
patients and controls on each component (μGM, μWM, CGM / CWM). Age and gender were used
as covariates.
The global averaging approach consisted in analysing mean T1 relaxation times in each
DGMN by performing a two-sample t-tests between RRMS patients and controls.
Results
Qualitative assessment
Qualitative comparison between the concentration maps obtained from 3T data with two his-
tological slices obtained from Sadikot and Chakravarty [15,16] showed a number of similar
details. The first slice shows the histology of the thalamus, the caudate and the putamen (Fig
1): neuronal nuclei in red, and myelin in blue. While the concentration of nuclei in the puta-
men and caudate appears homogeneous, the thalamus shows a variable amount of nuclei
Fig 1. Comparison between GM concentration map of 3 healthy subjects at 3T and an histological slice [15]. Histological data show outline of nuclei of
the human thalamus on a coronal Myelin-Nissl-stained section (right). The histologic sections are taken at the level of the sensory thalamus. Thalamic nuclei
are outlined using the terminology in Schaltenbrand’s atlas according to Hassler. The concentration maps were estimated using the whole-brain T1 maps of 3
healthy subjects randomly chosen. In the zoomed area and the histological slice, the DGMN are delineated as follows: thalamus in blue, putamen in yellow,
caudate in green.
doi:10.1371/journal.pone.0148631.g001
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which gradually increases towards the ventricles. The concentration maps estimated from the
T1 map at 3T show very similar homogeneity in the GM concentration of the caudate (delin-
eated in green) and putamen (delineated in yellow), while the thalamus (delineated in blue)
exhibits an increase of GM concentration going from the border of the structure to its center.
The red coloration in the histological slice shows a higher concentration of neuronal nuclei in
the caudate than in the putamen. The GM concentration map reflects this difference as the cau-
date appears brighter than the putamen for the 3 subjects. We also noticed a higher GM con-
centration in caudate than in the lateral part of the thalamus in the GM concentration maps,
while coloration appears less red in histological data of the lateral part of the thalamus which
may reflect presence of myelin. Furthermore, the concentration maps visualized the red
nucleus and the locus niger as reported by histological data.
Similar observations are made in others slices from the estimated concentration maps of 3
HC scanned at 7T compared with histological staining [16]. Due to the higher spatial resolu-
tion at 7T (Fig 2), images revealed an additional detail, a GM bridge between the caudate and
the putamen, which is clearly observable on stained images proposed in [16].
Group comparison using MANOVA and global averaging
The multivariate analysis of T1 characteristic intensities and concentrations ratio revealed a
significant difference in the thalamus of RRMS patients (pCorrected = 0.0016).
The analysis of the tissue T1 pooled intensities and concentrations showed a significant
increase of 3% of the GM pooled intensity (μGM) in the RRMS patients (Controls: μGM =
1389 ± 47 ms; Patients: μGM = 1427 ± 40 ms; p = 0.016), while the WM pooled intensity (μWM)
(0.6%) and the concentration ratio (-1%) were not found significantly different (Controls: μWM
= 912 ± 18 ms, μratio = 0.62 ± 0.08; Patients: μWM = 918 ± 14 ms, μratio = 0.61 ± 0.07) (Fig 3).
Fig 2. Comparison between GM concentration map of 3 healthy subjects at 7T and an histological
slice from a healthy human subject [16]. The concentration map were estimated using the whole-brain T1
map. In the zoomed area of GM concentration map we can observe the gray matter bridge present in the
histological slice between the caudate and the putamen.
doi:10.1371/journal.pone.0148631.g002
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The putamen, caudate and pallidum did not show any significant changes between RRMS
patients and HC using the multivariate analysis (Fig 4).
The global averaging analysis showed significant differences in the thalamus but also in the
putamen between RRMS patients and HC. In both structures, we observed a significant T1
increase in RRMS patients compared with HC (thalamus: p = 0.038; HC: μT1 = 1094 ± 33 ms;
RRMS: μT1 = 1110 ± 22 ms; putamen: p = 0.026; HC: μT1 = 1136 ± 35 ms; RRMS: μT1 =
1156 ± 27 ms, Fig 5).
Discussion
This study presents a new approach to disentangle GM andWM components in regions
affected by partial volume in MRI like the thalamus and the basal ganglia.
The proposed methodology provides quantitative estimations of GM andWM concentra-
tions and T1 relaxometry times by pooling intensity values that are characteristic for GM and
WMwithin a particular region. This opens new perspectives for the evaluation of the nature of
pathological processes.
In this study, we used an in-house algorithm [11] to estimate tissue concentrations and
characteristic intensities. The qualitative comparison of the estimated tissue concentration
maps with histological data showed remarkable similarities, including the heterogeneity of cel-
lular concentrations in the thalamus, and the variable amount of myelin among the DGMN. In
Fig 3. Boxplots of theWM and GM of the thalamus for RRMS patients and controls using the
proposed PVmethod. It shows significant increase in the T1 of the GM components between the RRMS
patients and HC.
doi:10.1371/journal.pone.0148631.g003
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summary, these findings provide qualitative evidence of the relevance of the partial volume
estimation proposed by Roche et al. [11] in deep GM regions.
Group analysis using MANOVA based on T1 relaxation times and concentrations of each
deep GM nucleus showed significant differences in the thalamus between patients and controls
(p = 0.0016). The analysis of the thalamus further revealed that the observed differences were
due to an increase of the intrinsic T1 value of the GM in RRMS patients (p = 0.016; 3%), with
no significant changes in the T1 of the WM component nor the WM/GM concentration ratio.
The global averaging method revealed significant changes in the thalamus with a less signifi-
cant p-value (p = 0.038) than the MANOVA, but it also detected significant changes in the
putamen (p = 0.026), while the MANOVA showed no significance (p = 0.4). In addition, the
analysis of tissue T1 pooled intensities and concentrations in the putamen did not show signifi-
cant changes between RRMS patients and controls (pGM_T1 = 0.1; pWM_T1 = 0.16; pratio = 0.13).
This result shows that an accumulation of non-significant small effects in each component
(GM andWM pooled intensities and concentrations increased in the putamen) can become
significant when combined. This observation suggests that although it does not identify the
source of intensity changes, the global averaging method appears more sensitive to detect
changes than the MANOVA. Nevertheless, considering the increased number of features (3
features instead of 1) analyzed in the MANOVA a larger cohort would be required to assign
observed differences in average T1 values to specific changes in GM or WM.
Fig 4. Boxplots of theWM and GM of the putamen for RRMS patients and controls using partial
volumemethod. This method showed no significant increase in the T1 of the GM andWM components
neither concentration ratio between the RRMS patients and HC.
doi:10.1371/journal.pone.0148631.g004
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As all patients were under the same medications at scan time and the use of covariates such
as age, gender in our analyses, we stated that the differences observed between patients and HC
were mainly due to pathological effects. Clinically these results suggest that thalamic pathology
in our population of early RRMS patients mainly affects the GM pool, while in the putamen
the WM and GM components appeared equally affected. From a pathophysiological viewpoint,
these findings might reflect the substantial neuronal damage that has been described in the
thalamus of multiple sclerosis patients in previous neuropathological studies [18–22]. Cifelli
et al. indeed observed thalamic volume reduction combined with N-acetylaspartate concentra-
tion and neuronal density decrease in thalamus of advanced MS patients [18], while a histo-
pathological study showed evidence of deep GM structures atrophy correlated with neuronal
loss by analyzing hippocampal autopsy tissue of MS patients [20]. Neuronal injury in the thala-
mus may be the consequence of wallerian or transynaptic degeneration and of injury from
cytokines, oxidative stress, glutamate excitotoxicity, and CD8 T-cell–citotoxicity [19,22].
Although the causes of GM injuries in MS remains poorly understood, the GM pathologies in
Fig 5. Boxplot of mean T1 in the thalamus and putamen using global averagingmethod. This method
showed significant increase of T1 in both ROIs by RRMS patients compared with HC.
doi:10.1371/journal.pone.0148631.g005
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DGMN appear throughout all disease stages and involves at a time inflammatory and neurode-
generative processes [21]. Interestingly, the fact that we did not detect changes in the GM con-
centration might indicate a stage of damage that precedes a loss of GM in the end-thalamic
volume [23], which may provide in the future more information on the pathogenesis of GM
alteration in DGMN.
Although global averaging methods remain sensitive ways to perform region-wise group
comparisons, the combination of these methods with the proposed PV estimation approach
provided additional information about the processes underlying thalamic alterations in our
cohort of MS patients. The presented methodology renders possible an in-depth characteriza-
tion of DGMN tissue that helps to identify diffuse inflammatory or neurodegenerative patholo-
gies affecting the basal ganglia and the thalamus.
Supporting Information
S1 Fig. Comparison between 2 axial slices of GM concentration maps (first row) and Statis-
tical Parametric Mapping (SPM) GM probabilistic maps (second row) at 3T. The SPMmap
appears more binary, and some parts (pointed out by red arrows) of the thalamus and putamen
disappear compared with concentration maps.
(DOCX)
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